Workboat Indexes
All News about Exelixis Inc
![](https://g.foolcdn.com/editorial/images/720676/bear-market-stocks-plunge-crash-invest-correction-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/14/bmy_logo_light__953779f5c208d1cb068cd55fa66c4de5.png?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/720577/gettyimages-researcher-works-in-lab_computer.jpg)
![](https://mms.businesswire.com/media/20230210005374/en/785869/22/BMS_Exelixis.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/roce_image_119.jpeg?width=1200&height=800&fit=crop)
Looking Into Exelixis's Return On Capital Employed
February 08, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](https://mms.businesswire.com/media/20230210005378/en/1711269/22/Exelixis_Logo_RGB_2023.jpg)
![](https://g.foolcdn.com/editorial/images/719843/physician-shaking-patients-hand.jpg)
![](https://mms.businesswire.com/media/20230207005453/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Exelixis
February 06, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/718798/physician-going-over-results-with-patient.jpg)
6 Analysts Have This to Say About Exelixis
January 11, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/714267/doctor-holding-elderly-patients-hand.jpg)
What 5 Analyst Ratings Have To Say About Exelixis
December 09, 2022
Via Benzinga
![](https://mms.businesswire.com/media/20230202005807/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
From Exelixis, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2132.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 26, 2023
January 26, 2023
Via Benzinga
![](https://mms.businesswire.com/media/20230124006010/en/1679909/5/Exelixis_Logo_RGB_2023.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30578.jpeg?width=1200&height=800&fit=crop)
Where Exelixis Stands With Analysts
December 09, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/20/exelixis_id_rgb_2c.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230119005934/en/1691352/22/Exelixis_Logo_RGB_2023.jpg)
Exelixis Announces Update on Patent Litigation with MSN Laboratories
January 19, 2023
From Exelixis, Inc.
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://mms.businesswire.com/media/20230108005042/en/1679908/5/Exelixis_Logo_RGB_2023.jpg)
![](https://www.marketbeat.com/logos/articles/small_stock-image_317419908_S.jpg)
![](https://mms.businesswire.com/media/20230103005704/en/610803/5/exelixis_id_rgb_2c.jpg)
![](https://g.foolcdn.com/editorial/images/713916/gettyimages-1285551846.jpg)
![](https://mms.businesswire.com/media/20221221005589/en/611316/5/Exelixis_Logo_JPG.jpg)
![](https://g.foolcdn.com/editorial/images/713434/an-advisor-showing-a-tablet-to-a-couple.jpg)
![](https://g.foolcdn.com/editorial/images/712973/lab-technician-with-clipboard-and-test-tube-getty.jpg)
![](https://g.foolcdn.com/editorial/images/712062/bear-market-stocks-plunge-crash-invest-correction-getty.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.